Kalaris Therapeutics, Inc. SEC filings KLRS
Kalaris Therapeutics, Inc. has 699 filings in SEC EDGAR's recent list, going back to Oct 2, 2018. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 11, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Apr 13, 2026 | — |
| 424B3 | Prospectus | Apr 13, 2026 | — |
| S-3 | Shelf registration | Apr 3, 2026 | — |
| S-3 | Shelf registration | Apr 3, 2026 | — |
| S-8 | Employee stock plan registration | Mar 17, 2026 | — |
| S-8 | Employee stock plan registration | Jun 4, 2025 | — |
| 424B3 | Prospectus | Feb 28, 2025 | — |
| 424B3 | Prospectus | Feb 10, 2025 | — |
| S-4/A | Filing | Feb 3, 2025 | — |
| S-4/A | Filing | Jan 17, 2025 | — |
| S-4 | Registration for a merger or exchange | Dec 9, 2024 | — |
| 424B5 | Prospectus supplement | Jun 22, 2023 | — |
| 424B5 | Prospectus supplement | Jun 21, 2023 | — |
| S-8 | Employee stock plan registration | Feb 15, 2023 | — |
| S-3 | Shelf registration | Feb 15, 2023 | — |
| 424B5 | Prospectus supplement | Jul 27, 2022 | — |
| POS AM | Filing | Feb 18, 2022 | — |
| POS AM | Filing | Feb 10, 2022 | — |
| S-8 | Employee stock plan registration | Feb 10, 2022 | — |
| S-3ASR | Automatic shelf registration | Aug 6, 2021 | — |
| S-8 | Employee stock plan registration | Feb 12, 2021 | — |
| S-8 | Employee stock plan registration | Jul 31, 2020 | — |
| 424B4 | Prospectus | Jul 30, 2020 | — |
| S-1MEF | Filing | Jul 30, 2020 | — |
| S-1/A | Amended registration statement | Jul 23, 2020 | — |
| S-1 | Registration statement | Jul 6, 2020 | — |
Showing 26 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- KLRS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Berkeley Heights, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1754068
- Former names
- Allovir, Inc. (until Mar 12, 2025); ViraCyte, Inc. (until Oct 2, 2018)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.